ZA201906513B - Anti-pd-l1 antibody and use thereof - Google Patents

Anti-pd-l1 antibody and use thereof

Info

Publication number
ZA201906513B
ZA201906513B ZA2019/06513A ZA201906513A ZA201906513B ZA 201906513 B ZA201906513 B ZA 201906513B ZA 2019/06513 A ZA2019/06513 A ZA 2019/06513A ZA 201906513 A ZA201906513 A ZA 201906513A ZA 201906513 B ZA201906513 B ZA 201906513B
Authority
ZA
South Africa
Prior art keywords
antibody
Prior art date
Application number
ZA2019/06513A
Inventor
Yan Lavrovsky
Ting Xu
Sergei Barbashov
Alexey Repik
Mikhail Samsonov
Vasily Ignatiev
Shorena Archuadze
Original Assignee
R Pharm Overseas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2018/028206 external-priority patent/WO2018195226A1/en
Application filed by R Pharm Overseas Inc filed Critical R Pharm Overseas Inc
Publication of ZA201906513B publication Critical patent/ZA201906513B/en

Links

ZA2019/06513A 2017-04-18 2019-10-03 Anti-pd-l1 antibody and use thereof ZA201906513B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2017028206 2017-04-18
PCT/US2018/028206 WO2018195226A1 (en) 2017-04-18 2018-04-18 Anti-pd-l1 antibody and use thereof

Publications (1)

Publication Number Publication Date
ZA201906513B true ZA201906513B (en) 2022-04-28

Family

ID=81307573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2019/06513A ZA201906513B (en) 2017-04-18 2019-10-03 Anti-pd-l1 antibody and use thereof

Country Status (1)

Country Link
ZA (1) ZA201906513B (en)

Similar Documents

Publication Publication Date Title
IL268206A (en) Bcma-targeting antibody and use thereof
IL273411A (en) Anti-pd-l1 antibody and uses thereof
HK1259426A1 (en) Anti-pd-l1 antibodies and uses thereof
HK1255604A1 (en) Anti-pd-l1 antibodies and uses thereof
IL267942B (en) Anti-cd73 antibodies and uses thereof
ZA201902533B (en) Anti-pd-l1 antibodies and variants
SG10201912199XA (en) Anti-tim-3 antibodies and use thereof
ZA202006904B (en) Anti-il-4r antibody and use thereof
IL268734A (en) Anti-lag-3 antibodies and uses thereof
IL268700A (en) Anti-phf-tau antibodies and uses thereof
SG11202100746WA (en) Anti-tigit antibody and use thereof
ZA202000113B (en) Anti-ctla-4 antibodies and uses thereof
IL279455A (en) Anti-pd-1 antibodies and uses thereof
IL275734B (en) Anti-pd-l1 antibodies and uses thereof
EP3541840C0 (en) Anti-hla-g antibodies and use thereof
IL269134A (en) Anti-par2 antibodies and uses thereof
SG11202104240TA (en) Cll1-targeting antibody and application thereof
IL268112A (en) Anti-tgf-beta antibodies and their use
ZA202006066B (en) Anti-hla-g antibodies and use thereof
ZA202006255B (en) Anti-pd-l1 antibody and use thereof
IL268051A (en) Idiotypic antibodies against anti-pd-l1 antibodies and uses thereof
EP3612565A4 (en) Anti-pd-l1 antibody and use thereof
IL265485A (en) Diagnostic anti-pd-l1 antibody and use thereof
IL263242A (en) Cytosol-penetrating antibody and use thereof
IL282707A (en) Anti-tim-3 antibodies and their use